Neoleukin Therapeutics Inc (NASDAQ:NLTX)

3.60
Delayed Data
As of 4:00pm ET
 +0.13 / +3.75%
Today’s Change
1.90
Today|||52-Week Range
4.70
+41.45%
Year-to-Date
No recent news for Neoleukin Therapeutics Inc.

Today’s Trading

Previous close3.47
Today’s open3.60
Day’s range3.53 - 3.60
Volume25
Average volume (3 months)31,747
Market cap$37.6M
Data as of 4:00pm ET, 12/07/2023

Growth & Valuation

Earnings growth (last year)+5.48%
Earnings growth (this year)--
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.56

Competitors

 Today’s
change
Today’s
% change
SLSSellas Life Sciences...-0.02-1.94%
SLGLSol Gel Technologies...+0.01+0.85%
----
--Nicox SA0.000.00%
Data as of 3:58pm ET, 12/07/2023

Financials

Last reporting dateAugust 16, 2023
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$57.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Seattle, Washington

Forecasts